Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A‐431) cells
Open Access
- 22 March 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 159 (7), 1497-1510
- https://doi.org/10.1111/j.1476-5381.2009.00627.x
Abstract
Background and purpose: Andrographolide is the active component of Andrographis paniculata, a plant used in both Indian and Chinese traditional medicine, and it has been demonstrated to induce apoptosis in different cancer cell lines. However, not much is known about how it may affect the key receptors implicated in cancer. Knowledge of how andrographolide affects receptor trafficking will allow us to better understand new mechanisms by which andrographolide may cause death in cancer cells. Experimental approach: We utilized the well-characterized epidermal growth factor receptor (EGFR) and transferrin receptor (TfR) expressed in epidermoid carcinoma (A-431) cells as a model to study the effect of andrographolide on receptor trafficking. Receptor distribution, the total number of receptors and surface receptors were analysed by immunofluorescence, Western blot as well as flow-cytometry respectively. Key results: Andrographolide treatment inhibited cell growth, down-regulated EGFRs on the cell surface and affected the degradation of EGFRs and TfRs. The EGFR was internalized into the cell at an increased rate, and accumulated in a compartment that co-localizes with the lysosomal-associated membrane protein in the late endosomes. Conclusion and implications: This study sheds light on how andrographolide may affect receptor trafficking by inhibiting receptor movement from the late endosomes to lysosomes. The down-regulation of EGFR from the cell surface also indicates a new mechanism by which andrographolide may induce cancer cell death.This publication has 59 references indexed in Scilit:
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatmentCancer Treatment Reviews, 2009
- Cancer prevention by tea: animal studies, molecular mechanisms and human relevanceNature Reviews Cancer, 2009
- Accumulation of Rhodopsin in Late Endosomes Triggers Photoreceptor Cell DegenerationPLoS Genetics, 2009
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cellsExperimental Cell Research, 2008
- Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCGInternational Journal of Molecular Sciences, 2008
- (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cellsCarcinogenesis: Integrative Cancer Research, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- ErbB receptors: from oncogenes to targeted cancer therapiesJCI Insight, 2007
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005